Associated tags: COVID-19, Health, Morrison, MD, Medical Devices, Vaccine, Pharmaceutical industry, Renewable energy, H. R. L. Morrison & Co, Patient, Infection, Pictor, Other Health, Infectious Diseases, Lazarus, General Health, Medical Supplies, Research, NP, Deen Dayal Mobile Health Clinic
COVID-19,
Medical Devices,
Medical Supplies,
Infectious Diseases,
Other Health,
Health,
General Health,
Agriculture,
Natural Resources,
Lazarus,
Animal Health,
ELISA,
Health,
Acceleration,
Morrison,
Infection,
Patient,
Ministry,
Disease,
COVID-19,
Growth,
H. R. L. Morrison & Co,
Renewable energy,
Pharmaceutical industry,
Vaccine,
Pictor,
MD This follows the recent successful launch of the PictArray SARS-CoV-2 IgG Antibody Test through Rako Science in New Zealand and key partners in the US.
Key Points:
- This follows the recent successful launch of the PictArray SARS-CoV-2 IgG Antibody Test through Rako Science in New Zealand and key partners in the US.
- The test better informs patients and doctors in determining whether the patient should be immunized or boosted, said Pictors Chief Medical Officer Tadd Lazarus, MD.
- Pictor has also leveraged its multiplex platform to develop an Animal Health business and is poised to launch two tests in Q2, 2023.
- Former Morrison & Co. CEO Marko Bogoievski is helping lead the current funding round following his investment and involvement in Pictor since early 2022.
Retrieved on:
Wednesday, April 13, 2022
Biotechnology,
Pharmaceutical,
Medical Supplies,
General Health,
Health,
Medical Devices,
Infectious Diseases,
Other Health,
Lazarus,
Public Health Emergency of International Concern,
CEO,
The Warehouse Group,
Gaps,
Warehouse,
Culture,
COVID-19,
NZD,
Twitter,
Software,
Public health emergency,
Research,
NP,
Leadership,
Morrison,
Deen Dayal Mobile Health Clinic,
World,
Infection,
Patient,
Growth,
Vaccination,
Vaccine,
H. R. L. Morrison & Co,
SP,
Mobility,
Antibody,
Partnership,
World Health Organization,
Severe acute respiratory syndrome coronavirus 2,
Accreditation,
University,
Pharmaceutical industry,
Renewable energy,
MD,
Pictor It will also indicate whether at-risk patients have failed to mount a detectable antibody response despite vaccination or infection (SP and NP negative).
Key Points:
- It will also indicate whether at-risk patients have failed to mount a detectable antibody response despite vaccination or infection (SP and NP negative).
- The PictArray SARS-CoV-2 Antibody Test is a high performance, all-in-one, NP/SP COVID-19 antibody test with serological differentiation.
- Pictor is pleased to partner with Mobility Health to offer such a unique and important test, said Howard Moore, CEO of Pictor.
- Mobility Health is a member of the Mason, Ohio living lab initiative to scale biohealth start-up companies.. More information can be found at www.mobilityhealthlab.com .
